Loading...
An analysis of common ethical justifications for compassionate use programs for experimental drugs
BACKGROUND: When a new intervention or drug is developed, this has to pass through various phases of clinical testing before it achieves market approval, which can take many years. This raises an issue for drugs which could benefit terminally ill patients. These patients might set their hopes on the...
Saved in:
| Published in: | BMC Med Ethics |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5069844/ https://ncbi.nlm.nih.gov/pubmed/27756370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-016-0145-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|